| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 02/16/2010 | US7662854 HIF hydroxylase inhibitors |
| 02/16/2010 | US7662816 Cognition activators; neurodegenerative disorders; Alzheimer's disease |
| 02/16/2010 | US7662813 Triazole compounds that modulate HSP90 activity |
| 02/16/2010 | US7662812 disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances |
| 02/16/2010 | CA2628224C Vinyl-pyrrolidinone cephalosporins with basic substituents |
| 02/16/2010 | CA2528008C 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 02/16/2010 | CA2442882C Sulphones which modulate the action of gamma-secretase |
| 02/11/2010 | WO2010017498A1 Methods of synthesizing n-hydroxysuccinimidyl carbonates |
| 02/11/2010 | WO2010017470A1 C7-fluoro substituted tetracycline compounds |
| 02/11/2010 | WO2010017060A1 Urea derivatives as antibacterial agents |
| 02/11/2010 | WO2010015816A2 Treatment of lysosomal storage disorders and other proteostatic diseases |
| 02/11/2010 | WO2010015090A1 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 02/11/2010 | WO2003018547A3 An improved process for the preparation of amorphous atorvastatin calcium salt (2:1) |
| 02/11/2010 | US20100036119 Fluorinating reagents and their preparation |
| 02/11/2010 | US20100036084 Biodegradable poly(beta-amino esters) and uses thereof |
| 02/11/2010 | US20100035959 Novel sphingosine kinase type 1 inhibitors, compositions and processes for using same |
| 02/11/2010 | US20100035948 Furanone compounds and lactam analogues thereof |
| 02/11/2010 | US20100035930 UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa |
| 02/11/2010 | US20100035929 Unnatural dispyrin analogues, preparation and uses thereof |
| 02/11/2010 | US20100035892 Method for assembling high-purity chemical libraries, compounds suppressing acetyl coenzyme a carboxylase activities discovered by same |
| 02/11/2010 | US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 02/11/2010 | US20100035185 Compound for Photoacid Generator, Resist Composition Using the Same, and Pattern-Forming Method |
| 02/11/2010 | US20100032241 Lubricating Systems |
| 02/11/2010 | CA2732883A1 C7-fluoro substituted tetracycline compounds |
| 02/11/2010 | CA2732045A1 Urea derivatives as antibacterial agents |
| 02/10/2010 | CN101643470A Alkyl ether derivatives or salts thereof |
| 02/10/2010 | CN101643443A Method for preparing amorphous atorvastatin calcium |
| 02/10/2010 | CN101643442A Seaweed bromphenol urea compounds, preparation method and application thereof |
| 02/09/2010 | US7659307 Heterocyclic carboxamides and their use as fungicides |
| 02/09/2010 | US7659305 4-carbo- or heterocyclic alkyl-, oxy-, amino-, and thio-substituted; e.g., 2S, 4S)-4-(3-Chloro-phenoxy)-pyrrolidine-2-carboxylic acid; controlling neurotransmitter release; uses include general treatment of pain, particularly neuropathic pain. |
| 02/09/2010 | US7659299 Compounds inhibiting the binding of sap for treating osteoarthritis |
| 02/09/2010 | CA2663141C Creatine pyroglutamic acid salts and methods for their production and use in individuals |
| 02/09/2010 | CA2482320C Methods for modulating phototoxicity |
| 02/09/2010 | CA2430827C Coniosetin and derivatives thereof, process for the preparation and the use thereof |
| 02/09/2010 | CA2299754C Hydroxy-substituted n-alkoxy hindered amines |
| 02/09/2010 | CA2291065C Raf kinase inhibitors |
| 02/09/2010 | CA2274201C Di-or triaza-spiro[4,5]decane derivatives |
| 02/09/2010 | CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |
| 02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 02/04/2010 | WO2010014179A1 Photolabile caged transition metal complexes and methods of using the same |
| 02/04/2010 | WO2010013011A1 P53 tumor suppressor protein activating |
| 02/04/2010 | WO2010012795A1 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues |
| 02/04/2010 | WO2010012794A1 Fungicide n-cycloalkyl-n-biphenylmethyl-carboxamide derivatives |
| 02/04/2010 | US20100029720 Carboxamide Derivatives As Muscarinic Receptor Antagonists |
| 02/04/2010 | US20100029686 Hcv protease inhibitors and uses thereof |
| 02/04/2010 | US20100029639 Ion channel modulating compounds and uses thereof |
| 02/04/2010 | US20100029609 Biaryl sulfonamide derivatives |
| 02/04/2010 | US20100028807 Imide Compound and Chemically Amplified Resist Composition Containing The Same |
| 02/04/2010 | US20100028535 Organometallic compounds and processes for preparation thereof |
| 02/04/2010 | US20100027192 Coated metal oxide nanoparticles and methods for producing same |
| 02/04/2010 | CA2731200A1 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues |
| 02/04/2010 | CA2731198A1 Fungicide n-cycloalkyl-n-biphenylmethyl-carboxamide derivatives |
| 02/03/2010 | EP2149550A1 Nitrogen-containing five-membered heterocyclic compound |
| 02/03/2010 | EP2149549A1 Pharmaceutical composition for prevention or treatment of hepatitis |
| 02/03/2010 | EP2148857A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists |
| 02/03/2010 | EP2148853A1 Insecticidal aryl pyrrolidines |
| 02/02/2010 | US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 02/02/2010 | US7655692 Dissolving atorvastatin in alcoholic solvent comprising methanol, ethanol, 1-propanol, or isopropanol; high speed evaporation by spray drying |
| 02/02/2010 | US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 02/02/2010 | US7655675 Gamma-secretase inhibitors |
| 02/02/2010 | US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases |
| 02/02/2010 | US7655155 bismethylmaleimide containing monomers containing at least one methyl group when cured used to produce a printed circuit board with high heat resistance and excellent mechanical properties. |
| 02/02/2010 | CA2578722C Process for atorvastatin calcium amorphous |
| 02/02/2010 | CA2530159C N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 02/02/2010 | CA2434162C Reaction method utilizing diaphram type catalyst and apparatus therefor |
| 02/02/2010 | CA2390858C N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 02/02/2010 | CA2345838C Method for the synthesis of radiolabeled compounds |
| 02/02/2010 | CA2333963C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 02/02/2010 | CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 01/28/2010 | WO2010011811A2 3-(phenoxyphenylmethyl)pyrrolidine compounds |
| 01/28/2010 | WO2010011284A2 Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
| 01/28/2010 | WO2010009508A1 Antiparasitic compounds |
| 01/28/2010 | US20100022784 N-Carbamoylmethyl-4-(R)-Phenyl-2-Pyrrolidinone, Method of its Preparation and Pharmaceutical Use |
| 01/28/2010 | US20100022773 Apoptosis promoters |
| 01/28/2010 | US20100022616 3-(phenoxyphenylmethyl)pyrrolidine compounds |
| 01/28/2010 | US20100022615 Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions |
| 01/28/2010 | US20100022605 N-hydroxyamide derivatives possessing antibacterial activity |
| 01/28/2010 | US20100022394 Products for the treatment of the iron chlorosis |
| 01/28/2010 | CA2731384A1 Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
| 01/27/2010 | EP2147911A1 Process for the preparation of levetiracetam |
| 01/27/2010 | EP2146951A2 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics |
| 01/27/2010 | EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | CN101633634A Method for extracting L-proline from fermentation liquor by membrane separation technology |
| 01/27/2010 | CN100584835C Novel medicinal salt for cinepazide and preparation method thereof |
| 01/27/2010 | CN100584827C Chiral sulfonamide aminol ligand, its preparing method and application |
| 01/27/2010 | CN100584819C Substituted 4-aminocyclohexanol derivatives |
| 01/26/2010 | US7652153 Caspase inhibitors and uses thereof |
| 01/26/2010 | US7652152 Synthetic method of optically pure (S)-3-hydroxypyrrolidine |
| 01/26/2010 | US7652151 Ketopyrroles useful as ligands in organic iridium compositions |
| 01/26/2010 | US7652149 Crystalline pyrazoles |
| 01/26/2010 | US7652062 Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 01/26/2010 | US7652061 (R)-1-{2-[3-(5-Methyl-2-pheny-oxazol-4-ylmethoxy)-phenyl]-acetyl}-pyrrolidine-2-carboxylic acid; dyslipidemia, hyperlipidemia, hypercholesteremia, or type-2 diabetes |
| 01/26/2010 | US7652060 Small molecule rotamase enzyme inhibitors |
| 01/26/2010 | US7652059 1-methyl-4-trifluoromethyl-1H-pyrrole-3-carboxylic acid [2-(1,3-dimethylbutyl)phenyl]amide; protecting plants against infestation by phytopathogenic microorganisms |
| 01/26/2010 | US7652021 (2S)-4,4-difluoro-1-{N-[3-(pyrimidin-2-ylamino)-1-adamantyl]glycyl}pyrrolidine-2-carbonitrile; dipeptidyl peptidase IV enzyme inhibitors; non-insulin dependent diabetes mellitus |